Achieve Better Outcomes
BVA helps end the debate by taking the guesswork out of determining a patient’s
volume status to significantly improve multiple measures of patient outcomes.
Significantly Reduce Heart Failure Mortality & Readmissions
Propensity matched-control trial in community hospital | n = 245, Mixed HFpEF/HFrEF
(P<0.001)
(P<0.001)
(P<0.001)
Blood Volume Measurements Improved ICU Survival
Prospective randomized control trial in surgical ICU | n = 100, 70% Septic Shock/Sepsis/40% ARDS
(P=0.03)
(P=0.14)
36 Hour Earlier
Treatment Decision
44% Change in Treatment
Strategy Versus Standard Care
Excellent Value in Healthcare
Blood Volume-Guided Treatment Extremely Cost-Effective
Retrospective analysis in hospitalized heart failure patients | n = 245, Mixed HFpEF/HFrEF
Well above the 0.227 previously reported
Than far below the threshold of $50,000
Approved for Reimbursement
Heart Failure
Critical Care
Sepsis
Syncope
Surgical Blood Loss
ARDS
Where Daxor BVA-100 Blood Test Makes an Impact
Watch Our Story
In the Spotlight
Watch Daxor CEO, Michael Feldschuh, Discuss How BVA-100 Technology is Joining to Fight COVID-19
News & Information
Partner With the Dedicated Leader in BVA
As the pioneer in blood volume analysis, Daxor provides education and the resources needed to ensure easy onboarding along with continuing support to drive maximum value from your BVA system throughout your facility. With a long-standing commitment to improving care and numerous studies validating our technology, Daxor is completely focused on advancing healthcare by enabling optimal fluid management with blood volume analysis. Our vision is optimal blood volume for all.
Volume is Vital. End the Debate With Daxor.
Call us at 865-425-0555.
Daxor Corporation is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for use in a broad range of medical and surgical conditions.
Daxor Corporation 350 Fifth Ave., Suite 4740, New York, NY 10118
Phone: 212-330-8500 | Fax: 516-828-4772
info@daxor.com | daxor.com
Made in the U.S.A.
COPYRIGHT 2021 © DAXOR CORPORATION – ALL RIGHTS RESERVED.
